Therapeutic Peptides Are Preferentially Solubilized in Specific Microenvironments within PEG–PLGA Polymer Nanoparticles
Source abstract
Abstract
High Resolution Image Download MS PowerPoint Slide Polymeric nanoparticles are a highly promising drug delivery formulation. However, a lack of understanding of the molecular mechanisms that underlie their drug solubilization and controlled release capabilities has hindered the efficient clinical translation of such technologies. Polyethylene glycol-poly(lactic- co -glycolic) acid (PEG–PLGA) nanoparticles have been widely studied as cancer drug delivery vehicles. In this letter, we use unbiased coarse-grained molecular dynamics simulations to model the self-assembly of a PEG–PLGA nanoparticle and its solubulization of the anticancer peptide, EEK, with good agreement with previously reported experimental structural data. We applied unsupervised machine learning techniques to quantify the conformations that polymers adopt at various locations within the nanoparticle. We find that the local microenvironments formed by the various polymer conformations promote preferential EEK solubilization within specific regions of the NP. This demonstrates that these microenvironments are key in controlling drug storage locations within nanoparticles, supporting the rational design of nanoparticles for therapeutic applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Polydiacetylene-based materials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, King’s College London, London SE1 1DB, United Kingdom
Biological Physics and Soft Matter Group, Department of Physics, King’s College London, London WC2R 2LS, United Kingdom
Kvantify Aps, DK-2300 Copenhagen S, Denmark
Funding
Engineering and Physical Sciences Research Council · Biotechnology and Biological Sciences Research Council
References (41)
Show source-provided references
1. 10.1080/1061186070179435310.1080/10611860701794353 ↗
2. 10.1016/j.msec.2015.11.06710.1016/j.msec.2015.11.067 ↗
3. 10.1016/j.addr.2003.12.00210.1016/j.addr.2003.12.002 ↗
4. 10.1038/nrd163210.1038/nrd1632 ↗
5. 10.3390/pharmaceutics1308113110.3390/pharmaceutics13081131 ↗
6. 10.1016/j.biomaterials.2011.07.03210.1016/j.biomaterials.2011.07.032 ↗
7. 10.1021/nl104117p10.1021/nl104117p ↗
8. 10.1016/j.biomaterials.2013.09.06210.1016/j.biomaterials.2013.09.062 ↗
9. 10.1016/j.biomaterials.2011.07.00410.1016/j.biomaterials.2011.07.004 ↗
10. 10.1016/j.ejpb.2015.07.00510.1016/j.ejpb.2015.07.005 ↗
11. 10.1002/app.5273210.1002/app.52732 ↗
12. 10.1016/j.eurpolymj.2021.11029210.1016/j.eurpolymj.2021.110292 ↗
13. 10.1021/acs.jcim.8b0064110.1021/acs.jcim.8b00641 ↗
14. 10.3390/pharmaceutics1206053310.3390/pharmaceutics12060533 ↗
15. 10.1016/S0168-3659(01)00218-810.1016/S0168-3659(01)00218-8 ↗
16. 10.1016/j.addr.2010.10.00810.1016/j.addr.2010.10.008 ↗
17. 10.1021/acs.jpcb.8b0374210.1021/acs.jpcb.8b03742 ↗
18. 10.1038/natrevmats.2016.1410.1038/natrevmats.2016.14 ↗
19. 10.3389/fmolb.2021.62701510.3389/fmolb.2021.627015 ↗
20. 10.1088/2053-1591/ab06d310.1088/2053-1591/ab06d3 ↗
21. 10.1016/j.carbpol.2020.11612410.1016/j.carbpol.2020.116124 ↗
22. 10.1002/advs.20210550610.1002/advs.202105506 ↗
23. 10.1016/0010-4655(95)00042-E10.1016/0010-4655(95)00042-E ↗
24. 10.1021/jp071097f10.1021/jp071097f ↗
25. 10.1016/j.bpc.2020.10645710.1016/j.bpc.2020.106457 ↗
26. 10.1021/acs.nanolett.0c0101110.1021/acs.nanolett.0c01011 ↗
27. 10.1021/acs.biomac.2c0090310.1021/acs.biomac.2c00903 ↗
28. 10.1021/ct700324x10.1021/ct700324x ↗
29. 10.1371/journal.pcbi.100081010.1371/journal.pcbi.1000810 ↗
30. 10.1016/j.eurpolymj.2020.11014910.1016/j.eurpolymj.2020.110149 ↗
31. 10.1021/acs.jpcb.8b0476010.1021/acs.jpcb.8b04760 ↗
32. 10.1002/jcc.2094510.1002/jcc.20945 ↗
33. 10.1021/acs.jctc.5b0051310.1021/acs.jctc.5b00513 ↗
34. 10.1021/ct700301q10.1021/ct700301q ↗
35. 10.1063/1.240842010.1063/1.2408420 ↗
36. 10.1021/ct900549r10.1021/ct900549r ↗
37. 10.1021/acs.macromol.0c0252310.1021/acs.macromol.0c02523 ↗
38. McInnes, L.; Healy, J.; Melville, J. Umap: Uniform manifold approximation and projection for dimension reduction. arXiv 2018, 10.48550/arXiv.1802.03426 (accessed on 2023-02-03).10.48550/arXiv.1802.03426 ↗
39. 10.21105/joss.0020510.21105/joss.00205 ↗
40. 10.1039/D3NR01204B10.1039/D3NR01204B ↗
41. King’s College London. King’s Computational Research, Engineering and Technology Environment (CREATE) 2022,10.18742/rnvf-m076.10.18742/rnvf-m076 ↗